COCA-COLA EUROPACIFIC PARTNE (CCEP)

GB00BDCPN049 - Common Stock

76.48  +0.11 (+0.14%)

Fundamental Rating

4

CCEP gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 33 industry peers in the Beverages industry. There are concerns on the financial health of CCEP while its profitability can be described as average. CCEP has a decent growth rate and is not valued too expensively.



5

1. Profitability

1.1 Basic Checks

CCEP had positive earnings in the past year.
CCEP had a positive operating cash flow in the past year.
CCEP had positive earnings in each of the past 5 years.
Each year in the past 5 years CCEP had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of 5.02%, CCEP is in line with its industry, outperforming 51.52% of the companies in the same industry.
The Return On Equity of CCEP (18.91%) is better than 69.70% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.11%, CCEP is in line with its industry, outperforming 45.45% of the companies in the same industry.
CCEP had an Average Return On Invested Capital over the past 3 years of 6.98%. This is significantly below the industry average of 13.01%.
The 3 year average ROIC (6.98%) for CCEP is below the current ROIC(7.11%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.02%
ROE 18.91%
ROIC 7.11%
ROA(3y)4.74%
ROA(5y)4.53%
ROE(3y)18.38%
ROE(5y)16.22%
ROIC(3y)6.98%
ROIC(5y)6.72%

1.3 Margins

With a Profit Margin value of 8.42%, CCEP perfoms like the industry average, outperforming 57.58% of the companies in the same industry.
CCEP's Profit Margin has improved in the last couple of years.
With a Operating Margin value of 11.78%, CCEP is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
CCEP's Operating Margin has improved in the last couple of years.
CCEP has a Gross Margin of 36.27%. This is amonst the worse of the industry: CCEP underperforms 87.88% of its industry peers.
CCEP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 11.78%
PM (TTM) 8.42%
GM 36.27%
OM growth 3Y15.03%
OM growth 5Y1.76%
PM growth 3Y24.77%
PM growth 5Y2.93%
GM growth 3Y1.02%
GM growth 5Y-1%

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CCEP is still creating some value.
CCEP has more shares outstanding than it did 1 year ago.
CCEP has less shares outstanding than it did 5 years ago.
CCEP has a better debt/assets ratio than last year.

2.2 Solvency

CCEP has an Altman-Z score of 2.00. This is not the best score and indicates that CCEP is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.00, CCEP perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
CCEP has a debt to FCF ratio of 7.23. This is a slightly negative value and a sign of low solvency as CCEP would need 7.23 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.23, CCEP is in line with its industry, outperforming 57.58% of the companies in the same industry.
CCEP has a Debt/Equity ratio of 1.32. This is a high value indicating a heavy dependency on external financing.
CCEP has a Debt to Equity ratio of 1.32. This is in the lower half of the industry: CCEP underperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.32
Debt/FCF 7.23
Altman-Z 2
ROIC/WACC1.01
WACC7.04%

2.3 Liquidity

A Current Ratio of 0.85 indicates that CCEP may have some problems paying its short term obligations.
The Current ratio of CCEP (0.85) is worse than 75.76% of its industry peers.
CCEP has a Quick Ratio of 0.85. This is a bad value and indicates that CCEP is not financially healthy enough and could expect problems in meeting its short term obligations.
CCEP has a worse Quick ratio (0.63) than 60.61% of its industry peers.
Industry RankSector Rank
Current Ratio 0.85
Quick Ratio 0.63

4

3. Growth

3.1 Past

The earnings per share for CCEP have decreased by -5.41% in the last year.
Measured over the past years, CCEP shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.35% on average per year.
The Revenue has been growing slightly by 6.31% in the past year.
CCEP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.70% yearly.
EPS 1Y (TTM)-5.41%
EPS 3Y49.42%
EPS 5Y14.35%
EPS Q2Q%-6.99%
Revenue 1Y (TTM)6.31%
Revenue growth 3Y19.95%
Revenue growth 5Y9.7%
Sales Q2Q%9.48%

3.2 Future

CCEP is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.42% yearly.
CCEP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.18% yearly.
EPS Next Y6.38%
EPS Next 2Y7.08%
EPS Next 3Y7.53%
EPS Next 5Y9.42%
Revenue Next Year11.87%
Revenue Next 2Y8.53%
Revenue Next 3Y7%
Revenue Next 5Y6.18%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 21.01 indicates a rather expensive valuation of CCEP.
The rest of the industry has a similar Price/Earnings ratio as CCEP.
CCEP's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.54.
With a Price/Forward Earnings ratio of 17.11, CCEP is valued on the expensive side.
Based on the Price/Forward Earnings ratio, CCEP is valued a bit cheaper than the industry average as 69.70% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.99, CCEP is valued a bit cheaper.
Industry RankSector Rank
PE 21.01
Fwd PE 17.11

4.2 Price Multiples

63.64% of the companies in the same industry are more expensive than CCEP, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CCEP is valued cheaply inside the industry as 81.82% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 20.17
EV/EBITDA 13.7

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)3.29
PEG (5Y)1.46
EPS Next 2Y7.08%
EPS Next 3Y7.53%

5

5. Dividend

5.1 Amount

CCEP has a Yearly Dividend Yield of 2.85%.
CCEP's Dividend Yield is a higher than the industry average which is at 3.05.
Compared to an average S&P500 Dividend Yield of 2.36, CCEP pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.85%

5.2 History

On average, the dividend of CCEP grows each year by 11.43%, which is quite nice.
CCEP has been paying a dividend for at least 10 years, so it has a reliable track record.
CCEP has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)11.43%
Div Incr Years4
Div Non Decr Years4

5.3 Sustainability

54.34% of the earnings are spent on dividend by CCEP. This is a bit on the high side, but may be sustainable.
CCEP's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP54.34%
EPS Next 2Y7.08%
EPS Next 3Y7.53%

COCA-COLA EUROPACIFIC PARTNE

NASDAQ:CCEP (12/26/2024, 1:48:05 PM)

76.48

+0.11 (+0.14%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)11-05 2024-11-05/bmo
Earnings (Next)02-14 2025-02-14/amc
Inst Owners34.95%
Inst Owner Change-2.86%
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap35.25B
Analysts80.91
Price Target87.28 (14.12%)
Short Float %1.49%
Short Ratio2.27
Dividend
Industry RankSector Rank
Dividend Yield 2.85%
Dividend Growth(5Y)11.43%
DP54.34%
Div Incr Years4
Div Non Decr Years4
Ex-Date11-15 2024-11-15 (1.34)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.46%
PT rev (3m)5.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-0.7%
EPS NY rev (3m)-1.06%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.31%
Revenue NY rev (3m)-1.62%
Valuation
Industry RankSector Rank
PE 21.01
Fwd PE 17.11
P/S 1.77
P/FCF 20.17
P/OCF 12.94
P/B 3.98
P/tB N/A
EV/EBITDA 13.7
EPS(TTM)3.64
EY4.76%
EPS(NY)4.47
Fwd EY5.85%
FCF(TTM)3.79
FCFY4.96%
OCF(TTM)5.91
OCFY7.73%
SpS43.19
BVpS19.23
TBVpS-20.64
PEG (NY)3.29
PEG (5Y)1.46
Profitability
Industry RankSector Rank
ROA 5.02%
ROE 18.91%
ROCE 9.72%
ROIC 7.11%
ROICexc 7.71%
ROICexgc 36.13%
OM 11.78%
PM (TTM) 8.42%
GM 36.27%
FCFM 8.78%
ROA(3y)4.74%
ROA(5y)4.53%
ROE(3y)18.38%
ROE(5y)16.22%
ROIC(3y)6.98%
ROIC(5y)6.72%
ROICexc(3y)7.9%
ROICexc(5y)7.41%
ROICexgc(3y)62.1%
ROICexgc(5y)49.4%
ROCE(3y)9.13%
ROCE(5y)8.81%
ROICexcg growth 3Y31.11%
ROICexcg growth 5Y13.41%
ROICexc growth 3Y21.27%
ROICexc growth 5Y4.3%
OM growth 3Y15.03%
OM growth 5Y1.76%
PM growth 3Y24.77%
PM growth 5Y2.93%
GM growth 3Y1.02%
GM growth 5Y-1%
F-Score3
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 1.32
Debt/FCF 7.23
Debt/EBITDA 3.61
Cap/Depr 108.92%
Cap/Sales 4.91%
Interest Coverage 10.31
Cash Conversion 84.01%
Profit Quality 104.28%
Current Ratio 0.85
Quick Ratio 0.63
Altman-Z 2
F-Score3
WACC7.04%
ROIC/WACC1.01
Cap/Depr(3y)77.82%
Cap/Depr(5y)76.76%
Cap/Sales(3y)3.72%
Cap/Sales(5y)4%
Profit Quality(3y)148.03%
Profit Quality(5y)156.16%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.41%
EPS 3Y49.42%
EPS 5Y14.35%
EPS Q2Q%-6.99%
EPS Next Y6.38%
EPS Next 2Y7.08%
EPS Next 3Y7.53%
EPS Next 5Y9.42%
Revenue 1Y (TTM)6.31%
Revenue growth 3Y19.95%
Revenue growth 5Y9.7%
Sales Q2Q%9.48%
Revenue Next Year11.87%
Revenue Next 2Y8.53%
Revenue Next 3Y7%
Revenue Next 5Y6.18%
EBIT growth 1Y-0.7%
EBIT growth 3Y37.97%
EBIT growth 5Y11.63%
EBIT Next Year48.85%
EBIT Next 3Y19.46%
EBIT Next 5Y14.24%
FCF growth 1Y-29.16%
FCF growth 3Y22.6%
FCF growth 5Y10.58%
OCF growth 1Y-8.42%
OCF growth 3Y23.49%
OCF growth 5Y9.21%